Stock Events

Stock Events

Immuno-Biological Laboratories. 

¥1,510
8
+¥36+2.44% Today

Statistics

Day High
1,505
Day Low
1,472
52W High
3,820
52W Low
434
Volume
8,803,900
Avg. Volume
-
Mkt Cap
14.07B
P/E Ratio
-
Dividend Yield
0.41%
Dividend
6.15

Upcoming

30
MAR 27
Dividend Ex
Estimated
 
30
MAR 28
Dividend Ex
Estimated
 

Dividends

0.41%Dividend Yield
Mar 26
¥6
Jun 13
¥5
Mar 8
¥5
Mar 6
¥5
Mar 5
¥15
10Y Growth
N/A
5Y Growth
N/A
3Y Growth
N/A
1Y Growth
N/A

Earnings

13MayExpected
Q3 2024
Q4 2024
Q1 2025
Q2 2025
Q3 2025
Q4 2025
Next
2.32
5.59
8.86
12.13
Expected EPS
N/A
Actual EPS
N/A

Financials

25.69%Profit Margin
Profitable
2019
2020
2021
2022
2023
2024
1.94BRevenue
498.09MNet Income

People Also Follow

This list is based on the watchlists of people on Stock Events who follow 4570.TSE. It's not an investment recommendation.
Alphabet
79493
GOOGL
Apple
69146
AAPL
Microsoft
64576
MSFT
Amazon
60260
AMZN

Competitors

This list is an analysis based on recent market events. It's not an investment recommendation.
Eisai
4523.TSE
Mkt Cap1.69T
Eisai Co., Ltd. competes in the pharmaceutical sector, focusing on neurology and oncology, areas that overlap with Immuno-Biological Laboratories' research interests.
Shionogi &.
4507.TSE
Mkt Cap2.12T
Shionogi & Co., Ltd. is involved in the research, development, manufacturing, and marketing of pharmaceuticals, including therapies that could compete with Immuno-Biological Laboratories' products.
Astellas Pharma
4503.TSE
Mkt Cap3.68T
Astellas Pharma Inc. operates in similar therapeutic areas as Immuno-Biological Laboratories, making it a direct competitor in the pharmaceutical and biotechnology industry.
Chugai Pharmaceutical
4519.TSE
Mkt Cap6.03T
Chugai Pharmaceutical Co., Ltd. specializes in biopharmaceuticals, competing in areas of research and development that may overlap with Immuno-Biological Laboratories' interests.
Daiichi Sankyo.
4568.TSE
Mkt Cap8.21T
Daiichi Sankyo Company, Limited focuses on pharmaceuticals in oncology and cardiovascular diseases, areas that could intersect with Immuno-Biological Laboratories' research and product offerings.
Kyowa Kirin.
4151.TSE
Mkt Cap1.75T
Kyowa Kirin Co., Ltd. focuses on pharmaceuticals and biotechnologies, including in areas that may compete with Immuno-Biological Laboratories' research and development efforts.
OtsukaLtd.
4578.TSE
Mkt Cap2.43T
Otsuka Holdings Co., Ltd. offers a diverse range of pharmaceutical products, some of which may compete directly with Immuno-Biological Laboratories' offerings.
Takeda Pharmaceutical
4502.TSE
Mkt Cap6.05T
Takeda Pharmaceutical Company Limited operates globally in various therapeutic areas, including those that Immuno-Biological Laboratories is involved in, making it a significant competitor.
Sumitomo Pharma.
4506.TSE
Mkt Cap419.94B
Sumitomo Pharma Co., Ltd. is engaged in the business of manufacturing, selling, and importing and exporting pharmaceuticals, competing in areas that overlap with Immuno-Biological Laboratories' focus.
Nippon Shinyaku.
4516.TSE
Mkt Cap517.95B
Nippon Shinyaku Co., Ltd. competes in the pharmaceutical industry, focusing on areas that could directly compete with Immuno-Biological Laboratories' products and research fields.

About

Immuno-Biological Laboratories Co., Ltd. researches, develops, manufactures, and supplies various immunological research reagents worldwide. It offers a range of antibodies and ELISA kits that are used for research and development in the fields of cancers and Alzheimer's disease, as well as lifestyle diseases, such as diabetes. The company also provides contract services to pharmaceutical firms and manufacturers of diagnostic products; and supplies antibodies for in-vitro diagnostic products, as well as licenses antibody drugs. In addition, it offers LipoTEST, a support testing services for animal medical care; LipoSEARCH lipid profiling and analyzing services; customized biomarker testing services for lifestyle related diseases; and other services, which include drug development and research support services. Further, the company develops Neosilk-Human Collagen I from transgenic silkworms for various cosmetic products; and proteins from transgenic silkworms for use in various drugs. Its antibodies serve pharmaceutical firms, universities, and laboratories in hospitals, and testing centers. The company was incorporated in 1982 and is headquartered in Fujioka, Japan.
Show more...
CEO
Tsutomu Seito
Employees
63
Country
Japan
ISIN
JP3921300004

Listings

TSE
JP
4570.TSE

0 Comments

Share your thoughts

FAQ

What is Immuno-Biological Laboratories. stock price today?▼
The current price of 4570.TSE is ¥1,510 JPY — it has increased by +2.44% in the past 24 hours. Watch Immuno-Biological Laboratories. stock price performance more closely on the chart.
What is Immuno-Biological Laboratories. stock ticker?▼
Depending on the exchange, the stock ticker may vary. For instance, on exchange Immuno-Biological Laboratories. stocks are traded under the ticker 4570.TSE.
Is Immuno-Biological Laboratories. stock price growing?▼
4570.TSE stock has risen by +4.68% compared to the previous week, the month change is a +5.19% rise, over the last year Immuno-Biological Laboratories. has showed a +237.61% increase.
What is Immuno-Biological Laboratories. market cap?▼
Today Immuno-Biological Laboratories. has the market capitalization of 14.07B
When is the next Immuno-Biological Laboratories. earnings date?▼
Immuno-Biological Laboratories. is going to release the next earnings report on May 13, 2026.
What were Immuno-Biological Laboratories. earnings last quarter?▼
4570.TSE earnings for the last quarter are 11.15 JPY per share, whereas the estimation was N/A JPY resulting in a N/A surprise. The estimated earnings for the next quarter are N/A JPY per share.
What is Immuno-Biological Laboratories. revenue for the last year?▼
Immuno-Biological Laboratories. revenue for the last year amounts to 1.94B JPY.
What is Immuno-Biological Laboratories. net income for the last year?▼
4570.TSE net income for the last year is 498.09M JPY.
Does Immuno-Biological Laboratories. pay dividends?▼
Yes, 4570.TSE dividends are paid semi-annual. The last dividend per share was 6 JPY. As of today, Dividend Yield (FWD)% is 0.41%.
How many employees does Immuno-Biological Laboratories. have?▼
As of April 17, 2026, the company has 63 employees.
In which sector is Immuno-Biological Laboratories. located?▼
Immuno-Biological Laboratories. operates in the Health & Wellness sector.
When did Immuno-Biological Laboratories. complete a stock split?▼
The last stock split for Immuno-Biological Laboratories. was on September 26, 2013 with a ratio of 10:1.
Where is Immuno-Biological Laboratories. headquartered?▼
Immuno-Biological Laboratories. is headquartered in Fujioka, Japan.